Koji Ando

USPTO Granted Patents = 16 (Patent Applications = 9)

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 84(Granted Patents)

Location History:

Yokohama, JP (1994)
Tatsuki, JP (2004)
Chita-gun, JP (2009 - 2012)
Osaka, JP (2006 - 2015)
Takatsuki, JP (1998 - 2017)

Company Filing History:

Years Active: 1994-2017

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9624155 - Iron (III) citrate, substantially free of beta-iron hydroxide oxide (2017-04-18),

2. 8981103 - Stable crystal of 4-oxoquinoline compound (2015-03-17),

3. 8420821 - Process for production of 4-oxoquinoline compound (2013-04-16),

4. 8383819 - Method for producing 4-oxoquinoline compound (2013-02-26),

5. 8158650 - Substituted phenylmethyl bicyclocarboxyamide compounds (2012-04-17),

6. 7964732 - Substituted bicyclocarboxyamide compounds (2011-06-21),

7. 7737163 - Benzimidazolone carboxylic acid derivatives (2010-06-15),

8. 7705020 - Benzimidazolone carboxylic acid derivatives (2010-04-27),

9. 7635704 - Stable crystal of 4-oxoquinoline compound (2009-12-22),

10. 7595329 - Benzimidazolone carboxylic acid derivatives (2009-09-29),

11. 6995271 - Production method of isoxazolidinedione compound (2006-02-07),

12. 6699996 - Production method of isoxazolidinedione compound (2004-03-02),

13. 6444827 - Production method of isoxazolidinedione compound (2002-09-03),

14. 6248897 - Process for producing isoxazolidinedione compound (2001-06-19),

15. 5750696 - Dioxacycloalkane compound having renin-inhibitory activity (1998-05-12),

**Title: Innovations by Inventor Koji Ando**

Introduction

Koji Ando, a prominent inventor based in Chita-gun, Japan, has made significant strides in the pharmaceutical field with a remarkable portfolio of five patents. His innovations focus on the development of compounds that target specific receptor overactivations, particularly those associated with pain management in mammals.

Latest Patents

Koji Ando's latest patents include "Substituted phenylmethyl bicyclocarboxyamide compounds," which provide compounds that hold promise for treating disease conditions related to the overactivation of the VR1 receptor. This invention also encompasses a pharmaceutical composition that utilizes the aforementioned compound. Another noteworthy patent is "Substituted bicyclocarboxyamide compounds," which similarly aims to treat conditions caused by VR1 receptor overactivation and includes a related pharmaceutical composition.

Career Highlights

Throughout his career, Koji Ando has demonstrated his expertise and dedication to advancing medical treatments through innovative compounds. His affiliation with Pfizer Corporation highlights his contribution to a leading company in the global pharmaceutical market. His work in developing targeted therapies showcases his commitment to improving patient outcomes.

Collaborations

In his journey, Koji Ando has collaborated with notable coworkers such as Noriaki Murase and Yoshinori Murata. These partnerships emphasize the importance of teamwork in the invention process, leading to innovative solutions in the pharmaceutical industry.

Conclusion

Koji Ando's contributions to the field of pharmaceuticals through his patented innovations reflect his role as a distinguished inventor. His work continues to pave the way for advancements in treating pain and related conditions, underscoring the vital intersection of science and healthcare.

This text is generated by artificial intelligence and may not be accurate.